Medicines Containing The Active Ingredient Erythropoietin Atc B03Xa01 In The Strength Over 10 000 Iu Per Dosage Unit

Deadline: 31 Aug 2026

Germany

Ref. No.: 8937415

EMD:Ref Document

Bid Value: Ref Document

224 Days Left

Medicines Containing The Active Ingredient Erythropoietin Atc B03Xa01 In The Strength Up To 10 000 Iu Per Dosage Unit

Deadline: 31 Aug 2026

Germany

Ref. No.: 8923452

EMD:Ref Document

Bid Value: Ref Document

224 Days Left

Medicines Containing The Active Ingredient Lipegfilgrastim Atc L03Aa14

Deadline: 31 Aug 2026

Germany

Ref. No.: 8922943

EMD:Ref Document

Bid Value: Ref Document

224 Days Left

Medicines Containing The Active Ingredient Treprostinil Atc B01Ac21

Deadline: 31 Aug 2026

Germany

Ref. No.: 8918861

EMD:Ref Document

Bid Value: Ref Document

224 Days Left

Supply Of Ppe Uniforms And Safety And Environmental Equipment

Deadline: 20 Aug 2026

Australia

Ref. No.: 8784322

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8764279

EMD:Ref Document

Bid Value: Ref Document

346 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8751368

EMD:Ref Document

Bid Value: Ref Document

346 Days Left

Fy25 29 Strategic Trends Research Initiative Broad Agency Announcement

Deadline: 01 Aug 2029

United States

Ref. No.: 8703781

EMD:Ref Document

Bid Value: Ref Document

1290 Days Left

Open House Discount Contracts 2024 11

Deadline: 31 Oct 2026

Germany

Ref. No.: 8612553

EMD:Ref Document

Bid Value: Ref Document

285 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8570586

EMD:Ref Document

Bid Value: Ref Document

346 Days Left

Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure

Deadline: 01 Sep 2026

Germany

Ref. No.: 8564108

EMD:Ref Document

Bid Value: Ref Document

225 Days Left

Open House Original Rebate Agreements 2024 09 Nintedanib Finished Medicinal Product Name Ofev R

Deadline: 31 Oct 2026

Germany

Ref. No.: 8552170

EMD:Ref Document

Bid Value: Ref Document

285 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8542116

EMD:Ref Document

Bid Value: Ref Document

346 Days Left

Redefining The Esophageal Stem Cell Niche Towards Targeting Of Squamous Cell Carcinoma

Deadline: 31 Aug 2026

Sweden

Ref. No.: 8352834

EMD:Ref Document

Bid Value: Ref Document

224 Days Left

An Object Oriented Approach To Color

Deadline: 28 Feb 2026

Germany

Ref. No.: 8352805

EMD:Ref Document

Bid Value: Ref Document

40 Days Left

Discover Tenders by Combat Uniforms Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Combat Uniforms Sector

Filter Your Search

FREE Trial plan for all new users!